Dr. Phillip Frost Amends OPKO Health Stake, Signals Ownership Change
Ticker: OPK · Form: SC 13D/A · Filed: Jan 24, 2024 · CIK: 944809
| Field | Detail |
|---|---|
| Company | Opko Health, INC. (OPK) |
| Form Type | SC 13D/A |
| Filed Date | Jan 24, 2024 |
| Risk Level | low |
| Pages | 7 |
| Reading Time | 8 min |
| Key Dollar Amounts | $0.01, $0.853, $0.9985, $3,654,120.67 |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: insider-ownership, amendment, beneficial-ownership
TL;DR
**Dr. Frost just updated his OPKO Health ownership, watch for market reaction!**
AI Summary
Dr. Phillip Frost, a significant insider, filed an Amendment No. 23 to his Schedule 13D on January 22, 2024, indicating a change in his beneficial ownership of OPKO Health, Inc. common stock. This filing updates previous disclosures regarding his substantial stake in the company. This matters to investors because changes in beneficial ownership by key insiders like Dr. Frost can signal their confidence (or lack thereof) in the company's future prospects, potentially influencing stock price movements.
Why It Matters
This filing updates the public on the beneficial ownership of a major insider, Dr. Phillip Frost, in OPKO Health, Inc., which can influence investor sentiment and stock valuation.
Risk Assessment
Risk Level: low — This filing is an amendment to a routine disclosure and does not inherently signal a high-risk event, but rather an update to existing information.
Analyst Insight
Investors should review the full Schedule 13D/A filing to understand the specific changes in Dr. Phillip Frost's beneficial ownership and assess if these changes align with their investment thesis for OPKO Health, Inc.
Key Players & Entities
- Dr. Phillip Frost (person) — reporting person and significant insider for OPKO Health, Inc.
- OPKO Health, Inc. (company) — the issuer of the securities
- January 22, 2024 (date) — date of the event requiring the filing
- Amendment No. 23 (number) — the specific amendment number to the Schedule 13D filing
- $0.01 (dollar_amount) — par value per share of OPKO Health Common Stock
FAQ
What type of filing is this document?
This document is an SC 13D/A, specifically Amendment No. 23, filed under the Securities Exchange Act of 1934.
Who is the 'Name of Issuer' for the securities discussed in this filing?
The 'Name of Issuer' is OPKO Health, Inc., with a CUSIP Number of 68375N103 for its Common Stock, par value $0.01 per share.
Who is the 'reporting person' or 'filer' of this Schedule 13D/A?
The reporting person is FROST PHILLIP MD ET AL, with a Central Index Key (CIK) of 0000898860.
What was the date of the event that required this filing?
The date of the event which required the filing of this statement was January 22, 2024.
Who is authorized to receive notices and communications regarding this filing?
Camielle Green, Associate General Counsel, Secretary at OPKO Health, Inc., located at 4400 Biscayne Boulevard, Miami, Florida 33137, with telephone (305) 575-4100, is authorized to receive notices and communications.
Filing Stats: 2,086 words · 8 min read · ~7 pages · Grade level 8.6 · Accepted 2024-01-24 16:01:09
Key Financial Figures
- $0.01 — me of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securiti
- $0.853 — the open market at prices ranging from $0.853 to $0.9985 per share for an aggregate p
- $0.9985 — market at prices ranging from $0.853 to $0.9985 per share for an aggregate purchase pri
- $3,654,120.67 — gregate purchase price of approximately $3,654,120.67 . The following table sets forth the in
Filing Documents
- pfro20240124_sc13da.htm (SC 13D/A) — 108KB
- 0001437749-24-002037.txt ( ) — 110KB
(a)-(d) is deleted in its entirety and replaced with the following text
Item 5 (a)-(d) is deleted in its entirety and replaced with the following text: (a)-(b) Gamma Trust directly beneficially owns 205,868,225 shares of Common Stock. The 205,868,225 total shares of Common Stock beneficially owned by Gamma Trust constitute approximately 29.5% of the Issuer's outstanding shares of Common Stock, based upon (i) 696,991,677 shares of Common Stock outstanding as of January 22, 2024 as communicated by the Issuer to the Reporting Person. Dr. Frost is the sole trustee of Gamma Trust and holds sole voting and dispositive power with respect to 205,868,225 shares of Common Stock. Frost Nevada directly beneficially owns 30,127,177 shares of Common Stock. The 30,127,177 total shares of Common Stock beneficially owned by Frost Nevada constitute approximately 4.3% of the Issuer's outstanding shares of Common Stock, based upon 696,991,677 shares of Common Stock outstanding as of January 22, 2024 as communicated by the Issuer to the Reporting Person. Dr. Frost is the sole trustee of Frost Nevada and holds sole voting and dispositive power with respect to 30,127,177 shares of Common Stock. Dr. Frost, as the sole trustee of Gamma Trust, may be deemed to beneficially own the 205,868,225 shares of Common Stock beneficially owned by Gamma Trust. Dr. Frost, as the sole trustee of Frost Nevada may be deemed to beneficially own the 30,127,177 shares of Common Stock beneficially owned by Frost Nevada. In addition, the Phillip and Patricia Frost Philanthropic Foundation, Inc., which is controlled by Dr. Frost and his wife, owns 2,851,830 shares of Common Stock. Dr. Frost individually owns 3,068,951 shares of Common Stock and options to acquire 2,787,500 shares of Common Stock, which are exercisable within 60 days, and has sole voting and dispositive power over each. The 244,703,683 shares of Common Stock beneficially owned by Dr. Frost constitute approximately 35.0% of the Issuer's outstanding shares of Common Stock, based upon (i) 696,991,677 shares of Commo
SIGNATURES
SIGNATURES After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Frost Gamma Investments Trust Dated: January 24, 2024 By: /s/ Phillip Frost, M.D. Name: Phillip Frost, M.D. Title: Sole Trustee Frost Nevada Investments Trust Dated: January 24, 2024 By: /s/ Phillip Frost, M.D. Name: Phillip Frost, M.D. Title: Sole Trustee Dated: January 24, 2024 By: /s/ Phillip Frost, M.D. Name: Phillip Frost, M.D. Title: Phillip Frost, M.D., Individually